Clinical Trials Browser

Hereditary leiomyomatosis and renal cell cancer, Fumaric aciduria, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Kidney Neoplasms, Adenocarcinoma, Clear Cell

NCT06218433 2025-11-18

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

Phase NA Recruiting

200 enrolled

GastrointestinalGenitourinary

Urogenital Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary

NCT06394869 2025-11-10

CREDIBLE

Phase NA Recruiting

1,000 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00567684 2025-10-28

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Phase NA Active not recruiting

133 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04693377 2025-10-27

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Phase NA Recruiting

40 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasm Metastasis, Prostatic Neoplasms, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT07164950 2025-09-15

Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients

Phase NA Recruiting

58 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT06262516 2025-09-05

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Phase NA Recruiting

94 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT06967961 2025-07-29

DP-PAN-CANCER

Phase NA Recruiting

450 enrolled

DermatologicGenitourinaryGynecologicSarcoma

Nonseminomatous germ cell tumor, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Kidney Neoplasms, Melanoma, Neoplasms, Sarcoma

NCT02968732 2025-07-04

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Phase NA Active not recruiting

65 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03988309 2025-05-31

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Phase NA Completed

554 enrolled

Genitourinary

Carcinoma, Transitional Cell, Hematuria

NCT06994078 2025-05-29

Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors

Phase NA Not yet recruiting

56 enrolled

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Lung Neoplasms

NCT05646485 2025-04-13

Bladder Cancer Screening Trial

Phase NA Recruiting

1,000 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Smoking Cessation

Clinical Trials

Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

ASTRA

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

CREDIBLE

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

DP-PAN-CANCER

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors

Bladder Cancer Screening Trial